Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
SystImmune Inc.
Instituto do Cancer do Estado de São Paulo
Tempus AI